481 related articles for article (PubMed ID: 31138255)
1. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M
Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255
[TBL] [Abstract][Full Text] [Related]
2. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
Wang JL; Wang X; Yang D; Shi WJ
Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279
[TBL] [Abstract][Full Text] [Related]
3. miR-21, miR-106b and miR-375 as novel potential biomarkers for laryngeal squamous cell carcinoma.
Yu X; Wu Y; Liu Y; Deng H; Shen Z; Xiao B; Guo J
Curr Pharm Biotechnol; 2014; 15(5):503-8. PubMed ID: 24846066
[TBL] [Abstract][Full Text] [Related]
4. Droplet digital PCR and qRT-PCR to detect circulating miR-21 in laryngeal squamous cell carcinoma and pre-malignant laryngeal lesions.
Wei L; Mao M; Liu H
Acta Otolaryngol; 2016 Sep; 136(9):923-32. PubMed ID: 27067271
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.
Ayaz L; Görür A; Yaroğlu HY; Ozcan C; Tamer L
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1499-506. PubMed ID: 23817697
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-632 is a potential marker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Cao YC; Song LQ; Xu WW; Qi JJ; Wang XY; Su Y
Acta Otolaryngol; 2020 May; 140(5):418-421. PubMed ID: 32068453
[No Abstract] [Full Text] [Related]
7. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma.
Gao X; Wang Y; Zhao H; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
Oncotarget; 2016 Sep; 7(37):59664-59675. PubMed ID: 27517633
[TBL] [Abstract][Full Text] [Related]
8. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma.
Wang J; Zhou Y; Lu J; Sun Y; Xiao H; Liu M; Tian L
Med Oncol; 2014 Sep; 31(9):148. PubMed ID: 25099764
[TBL] [Abstract][Full Text] [Related]
9. Preliminary study using a small plasma extracellular vesicle miRNA panel as a potential biomarker for early diagnosis and prognosis in laryngeal cancer.
Zhang H; Chen Z; Huang Q; Guo Y; Wang M; Wu C
Cell Oncol (Dordr); 2023 Aug; 46(4):1015-1030. PubMed ID: 36964893
[TBL] [Abstract][Full Text] [Related]
10. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
11. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR
Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
13. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma.
Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL
J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462
[TBL] [Abstract][Full Text] [Related]
14. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
15. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
[TBL] [Abstract][Full Text] [Related]
17. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of serum miRNA let-7a for laryngeal carcinoma and effects of let-7a on proliferation and apoptosis of laryngeal carcinoma cells].
Zhou E; Luo L; Ma LJ; Yin J; Tan ZQ; Miao GY; Liu J; Xiao XP
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 54(7):534-539. PubMed ID: 31315362
[No Abstract] [Full Text] [Related]
19. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.
Zhang C; Wang C; Chen X; Yang C; Li K; Wang J; Dai J; Hu Z; Zhou X; Chen L; Zhang Y; Li Y; Qiu H; Xing J; Liang Z; Ren B; Yang C; Zen K; Zhang CY
Clin Chem; 2010 Dec; 56(12):1871-9. PubMed ID: 20943850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
